108 related articles for article (PubMed ID: 16610806)
21. Effects of losartan on angiotensin receptors in the hypertrophic rat heart.
Sim MK; Chen WS
Regul Pept; 2006 Dec; 137(3):140-6. PubMed ID: 16928404
[TBL] [Abstract][Full Text] [Related]
22. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.
Baumann M; Janssen BJ; Hermans JJ; Peutz-Kootstra C; Witzke O; Smits JF; Struijker Boudier HA
J Hypertens; 2007 Jan; 25(1):207-15. PubMed ID: 17143193
[TBL] [Abstract][Full Text] [Related]
23. A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic rats.
Izuhara Y; Sada T; Yanagisawa H; Koike H; Ohtomo S; Dan T; Ito S; Nangaku M; van Ypersele de Strihou C; Miyata T
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1767-73. PubMed ID: 18658044
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
Shah DI; Sharma M; Bansal Y; Bansal G; Singh M
Eur J Med Chem; 2008 Sep; 43(9):1808-12. PubMed ID: 18158200
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
26. Sartan-AT1 receptor interactions: in vitro evidence for insurmountable antagonism and inverse agonism.
Van Liefde I; Vauquelin G
Mol Cell Endocrinol; 2009 Apr; 302(2):237-43. PubMed ID: 18620019
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation.
Miyoshi M; Miyano K; Moriyama N; Taniguchi M; Watanabe T
Eur J Neurosci; 2008 Jan; 27(2):343-51. PubMed ID: 18190523
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and pharmacological evaluation of novel NO-releasing benzimidazole hybrids as potential antihypertensive candidate.
Zhang Y; Xu J; Li Y; Yao H; Wu X
Chem Biol Drug Des; 2015 May; 85(5):541-8. PubMed ID: 25283264
[TBL] [Abstract][Full Text] [Related]
30. A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage.
Takizawa S; Dan T; Uesugi T; Nagata E; Takagi S; van Ypersele de Strihou C; Miyata T
J Cereb Blood Flow Metab; 2009 Oct; 29(10):1665-72. PubMed ID: 19536069
[TBL] [Abstract][Full Text] [Related]
31. Beneficial effects of the combination of nifedipine and losartan in hypertensive Dahl salt-sensitive rats.
Tinel H
J Cardiovasc Pharmacol; 2007 Jul; 50(1):75-82. PubMed ID: 17666919
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities.
Zhu W; Da Y; Wu D; Zheng H; Zhu L; Wang L; Yan Y; Chen Z
Bioorg Med Chem; 2014 Apr; 22(7):2294-302. PubMed ID: 24613628
[TBL] [Abstract][Full Text] [Related]
34. Multivalent ligand-receptor interactions elicit inverse agonist activity of AT(1) receptor blockers against stretch-induced AT(1) receptor activation.
Qin Y; Yasuda N; Akazawa H; Ito K; Kudo Y; Liao CH; Yamamoto R; Miura S; Saku K; Komuro I
Hypertens Res; 2009 Oct; 32(10):875-83. PubMed ID: 19662020
[TBL] [Abstract][Full Text] [Related]
35. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
Aulakh GK; Sodhi RK; Singh M
Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
[TBL] [Abstract][Full Text] [Related]
36. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Devereux RB; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems.
Cappelli A; Nannicini C; Gallelli A; Giuliani G; Valenti S; Mohr Gl; Anzini M; Mennuni L; Ferrari F; Caselli G; Giordani A; Peris W; Makovec F; Giorgi G; Vomero S
J Med Chem; 2008 Apr; 51(7):2137-46. PubMed ID: 18318468
[TBL] [Abstract][Full Text] [Related]
38. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
[TBL] [Abstract][Full Text] [Related]
39. An angiotensin II receptor antagonist suppresses running-enhanced hippocampal neurogenesis in rat.
Mukuda T; Sugiyama H
Neurosci Res; 2007 Jun; 58(2):140-4. PubMed ID: 17397954
[TBL] [Abstract][Full Text] [Related]
40. Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats.
Alvarez Y; Pérez-Girón JV; Hernanz R; Briones AM; García-Redondo A; Beltrán A; Alonso MJ; Salaices M
J Pharmacol Exp Ther; 2007 Apr; 321(1):381-8. PubMed ID: 17244722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
